Starting antibacterial therapy for acute enteric infections in infants
The efficiency of starting antibacterial therapy with enteroraril, furazolidone, or amikacin for acute enteric infections was comparatively studied in 130 children aged 1 month to 3 years who had different types of the diarrheal syndrome. The use of enteroraril in the starting therapy (in combination with an antibiotic) for the moderate and severe forms of invasive and mixed diarrhea was found to produce a prompter therapeutic effect than did that with the other drugs, especially in normalizing the local symptoms of the disease with minor enteric microbiocenotic disorders during convalescence. The authors show it advisable to include enteroraril into the starting etiotropic therapy for osmotic diarrhea within the first three days of treatment until the etiologic agent of acute enteric infection is established.